Leslie V. Norwalk, Director: Neurocrine Biosciences NBIX Sell · Filed 05/14

Trade details

Type: Insider sale
Amount: $590,588.1
Shares · price: 3,810 sh · $155.01 a share
Held after: 2,429 sh
Stock: Neurocrine Biosciences NBIX
Person: Leslie V. NorwalkDirector
Trade date: 26/05/12
Filed: 26/05/14
Days to filing: 2 days

Sold 61.1% of holdings

Share of holding sold: 61.1%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 04/12~06/11

Leslie V. Norwalk's recent trades

Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$210.1K
1,250 sh
$210.1K
Filed 06/08
Traded 06/04
Leslie V. NorwalkDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$1M
6,310 sh
$1M
Filed 05/12
Traded 05/12
Leslie V. NorwalkDirector
Sell10b5-1 planGlobus Medical
Sell10b5-1 plan
Globus Medical
GMED
$202.2K
2,000 sh
$202.2K
Filed 01/12
Traded 01/08
Leslie V. NorwalkDirector
Planned sale10b5-1 planGlobus Medical
Planned sale10b5-1 plan
Globus Medical
GMED
$202K
2,000 sh
$202K
Filed 01/08
Traded 01/08
Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$761.2K
5,000 sh
$761.2K
Filed 25/12/17
Traded 25/12/15

Leslie V. Norwalk, Director — sold $590.6K of Neurocrine Biosciences NBIX · 61.1% of holdings · 10b5-1 plan | Whalegun